A UCLA study helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and introduces a new approach that paves the way for more personalized treatment strategies for patients with this deadly brain tumor.
People with chronic liver disease can be categorized into four distinct risk groups based on the different barriers they face in obtaining outpatient care, barriers that increase their odds of requiring hospitalization.
UCLA researchers have uncovered a surprising new role for netrin1, a crucial protein in neural development, as a regulator that limits bone morphogenetic protein signaling in the developing spinal cord.
After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality of life, particularly in bowel and sexual health, compared to conventional CT-guided treatment.
UCLA investigators have shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell/neuroendocrine prostate cancer.
The funding will support a new initiative aimed at reducing disparities in lung cancer screening across Los Angeles County.
UCLA Health experts Amy Cummings, MD, PhD, and Sha'Shonda Revels, MD, address frequently asked questions about the disease.
Dr. Sedrak, who directs the Cancer and Aging Program at the UCLA Health Jonsson Comprehensive Cancer Center(Link opens in new window), discusses what inspired his work, the challenges cancer survivors face as they age, and the exciting advancements in cancer and aging research that could reshape patient care in the years to come.
Researchers at UCLA Health have found that a person's risk of developing psychotic-like experiences may be influenced by both childhood attention problems and their genetic makeup.
In a new study, UCLA Health researchers have found that people who experienced discrimination had pro-inflammatory bacteria and gene activity in their gut microbiome that was different from those who did not experience discrimination.
UCLA scientists have identified the protein GPNMB as a critical regulator in the heart’s healing process after a heart attack.
An experimental therapeutic monoclonal antibody therapy could become the first to directly enhance tissue repair in the heart following a heart attack.
The UCLA Urology department has been awarded $6 million from the California Department of Health Care Services to continue providing vital care and critical services to underinsured and uninsured Californians diagnosed with prostate cancer.
UCLA's Dr. Luca Valle was awarded a $2.1 million grant from the U.S. Department of Veterans Affairs to develop new methods to better understand the clinical scope and biological factors that lead to prostate cancer coming back after radiation therapy.
With time being of the essence for patients facing one of cancer's most dire complications, UCLA researchers are working to create a new test to detect cancer’s spread to the central nervous system on the same day as the doctor’s visit.
The collaboration is backed by a substantial new investment from PICI, which recently committed $125 million(Link is external) (Link opens in new window) to expand research efforts across a collaborative consortium of immuno-oncology academic research institutions.
Medicare could save up to 74% of the money lost from discarded Alzheimer’s drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown away.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right